Breaking News: AHCO – Market Insights, Analysis & Latest Updates

AHCO

Earnings call: AdaptHealth Q3 2024 results reveal steady growth and challenges

AdaptHealth reported Q3 2024 revenue growth despite diabetes segment challenges. Focus is on operational improvements, financial health, and future growth opportunities while managing setbacks in diabetes.

investing.com • 06/11/2024 - 18:59 PM

AHCO

AdaptHealth shares plummet 14% as guidance disappoints

AdaptHealth's Q3 earnings missed expectations, leading to a 14% stock drop. Revenue guidance for 2024 was lowered, but CEO remains optimistic about growth opportunities.

investing.com • 05/11/2024 - 13:04 PM

Greed and Fear Index

Note: The data is for reference only.

Greed

Earnings call: AdaptHealth Q3 2024 results reveal steady growth and challenges

AdaptHealth shares plummet 14% as guidance disappoints

Currency